1. Bagatell FK, Bart BJ, Cole GW, Drake LA, Ellis CN, Fisher S, et al. Naftifine gel in the treatment of tinea pedis: two double-blind multi-centre studies. Cutis 1991;48:85-8.
2. Dobson RL, Binder R, Hickman JG, Katz HI, Landon RD, Rex IH, et al. Once-daily naftifine cream 1% (Naftin) in the treatment of tinea pedis. Clin Trials J 1989;26:418-23.
3. Klaschka F, Gartmann H, Weidinger G. Antimycotic naftifine: placebo-controlled comparison in tinea pedum. Z Hauktr 1984;59:1218-25.
4. Schachner LA, Bagatell FK, Whittington CV, Willis I, Sefton J. The safety and efficacy of Naftifine cream 1% in the treatment of tinea pedis. Adv Ther 1990;7:148-52.
5. Berman B, Ellis C, Leyden J, Lowe N, Savin R, Shupack J, et al. Efficacy of a one-week twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. J Am Acad Dermatol 1992;26:956-60.
6. Evans EGV, James IGV, Joshipura RC. Two-week treatment of tinea pedis with terbinafine: a placebo-controlled study. J Dermatol Treatment 1991;2:95-7.
7. Savin RC. Treatment of chronic tinea pedis (athletes foot type) with topical terbinafine. J Am Acad Dermatol 1990;23:786-9.
8. Savin R, Atton AV, Bergstrasser PR, Elewski B, Jones HE, Levine L, et al. Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multi-centre trials. J Am Acad Dermatol 1994;30:663-7.
9. Smith EB, Noppakun N, Newton RC. A clinical trial of topical terbinafine (a new allylamine antifungal) in the treatment of tinea pedis. J Am Acad Dermatol 1990;23:790-4.
10. Bagatell FK. Elimination of dermatophytes causing tinea pedis interdigitalis with once daily application of bifonazole 1% solution. Adv Ther 1986;3:265-71.
11. Coffey W. Management of tinea pedis interdigitalis with bifonazole 1% cream: double-blind study. Adv Ther 1986;3:301-7.
12. Izuno GT. A double-blind study of bifonazole 1% cream applied once daily in the treatment of tinea (pityriasis) versicolour and tinea pedis interdigitalis. Adv Ther 1986;3;308-33.
13. Smith EB, Tschen E. Treatment of interdigital tinea pedis and tinea (pityriasis) versicolour with bifonazole solution applied once daily. Adv Ther 1986;3:250-6.
14. Daily AD, Kramer KJ, Rex IH, Thorne EG. Econazole nitrate (Spectazole) cream 1%C a topical agent for the treatment of tinea pedis. Cutis 1985;35;278-80.
15. Ison AE, Lufrano L, Thorne EG. Once daily application of econazole nitrate in the treatment of tinea pedis. Adv Ther 1990;7:119-23.
16. Duncan WC. Tinea pedis: treatment with topical miconazole. Cutis 1975;16:647-9.
17. Gentles JC, Jones GR, Roberts DT. Efficacy of miconazole in the topical treatment of tinea pedis in sportsmen. Br J Dermatol 1975;93:79-84.
18. Mandy SH, Garrott TC. Miconazole treatment for severe dermatophytoses. JAMA 1974;230:72-5.
19. Ortiz LG, Papa PR. Topical miconazole nitrate therapy in tinea pedis and tinea versicolor. Clin Ther 1978;1:444-50.
20. Gomez EC, Huntley AC, Isseroff R, Tanji J. Efficacy of tolciclate solution in patients with tinea pedis. Clin Ther 1986;8:694-9.
21. Savin R, DeVillez RL, Elewski B, Hong S, Jones T, Lowe N, et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multi-centre double-blind trial. J Am Acad Dermatol 1997;36:15-9S.
22. Tschen EH, Elewski B, Gorsulowsky DC, Pariser DM. Treatment of interdigital tinea pedis with four-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol 1997;36:9-14.
23. Kligman AM, Bogaert H, Cordero C, Duncan WC, Savin RC, Shalita AR, et al. Evaluation of ciclopiroxolamine cream for treatment of tinea pedis: multi-centre double-blind comparative studies. Clin Ther 1985;7:409-17.
24. Chretien JH, Esswein JG, Sharpe LM, Kiely JJ, Lyddon FE. Efficacy of undecylinic acid-zinc undecylinate powder in culture-positive tinea pedis. Int J Dermatol 1980;19:51-4.
25. Fredriksson T, Faergemann J. Comparative study of the therapeutic effect of bifonazole and econazole in the treatment of dermatomycoses. In: Urabe H, ed. Proceedings of the international antifungal symposiumC bifonazole, 1982:120-5.
26. Privat Y, Konopka CA. A comparative controlled clinical trial of bifonazole versus econazole in superficial mycoses. In: Urabe H, ed. Proceedings of the international antifungal symposiumC bifonazole, 1982:136-40.
27. Bojanovsky A, Haas P. Antimycotic efficacy of naftifine: double-blind comparative study with bifonazole in tinea pedis. [German with English abstract.] Fortschr Med 1985;103:677-9.
28. Thomas DJ, Evans A. A study in industry of bifonazole (1% gel) and sulconazole cream in tinea pedis and tinea cruris. In: Hay RJ, ed. Advances in topical antifungal therapy, 1986:68-75.
29. Del Palacio A, Hernanz A, Lopez-Gomez S, Moreno-Palancar P, Gonzales-Lastra F. A clinical double-blind trial comparing amorolfine cream (0.5%) with bifonazole cream (1%) in the treatment of dermatomycoses. Clin Exp Dermatol 1989;14:141-4.
30. Carter VH. A controlled study of haloprogen and tolnaftate in tinea pedis. Curr Ther Res Clin Exp 1972;14:307-10.
31. Evans EGV, Dodman B, Williamson DM, Brown GJ, Bowen RG. Comparison of terbinafine and clotrimazole in treating tinea pedis. BMJ 1993;307:645-7.
32. Sanchez-Carazo JL, Fuente C, Oliver V, Umbert P. A comparative study of terbinafine. [Spanish with English abstract.] Acta Dermatol Sifiliogr 1994;85:388-94.
33. Vermeer BJ, Staats CCG, Van Houwelingen JC. Terbinafine versus miconazol bij patienten met tinea pedis. Ned Tijdschr Geneeskd 1996;140:1605-8.
34. Qadripur SA, Krause U. Double-blind trial of clotrimazole and econazole in tinea pedis. Mykosen 1979;22:28-34.
35. Kuhlwein A, Busch TH. Croconazole versus bifonazole in the local treatment of tinea inguinalis and tinea pedis. Therapiewoche 1990;40:1643-5.
36. Smith EB, Breneman DL, Griffith RF, Hebet AA, Hickman JG, Maloney JM, et al. Double-blind comparison of naftifine cream and clotrimazole betamethasone depropionate cream in the treatment of tinea pedis. J Am Acad Dermatol 1992;26:125-7.
37. Evans EGV, James IGV, Seaman RAJ, Richardson MD. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole-1% hydrocortisone in clinically diagnosed fungal infection of the skin. Br J Dermatol 1993;129:437-42.
38. Haas PJ, Tronnier H, Weidinger G. Naftifine in foot mycoses: double-blind therapeutic comparison with clotrimazole. [German with English abstract.] Mykosen 1985;28:33-40.
39. Kagawa S. Comparative clinical trial of naftifine and clotrimazole in tinea pedum, tinea cruris and tinea corporis. Mykosen 1985;28:82-8.
40. Plotkin E, Machtinger MA, Vlahos M, Lipkin L, Pascente RW, Joseph WS, et al. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. J Am Podiatr Med Assoc 1990;80:314-8.
41. Holti G. A double-blind controlled trial of Whitfield's ointment and Variotin in ringworm infections with a two year follow-up. Acta Dermatol Venereol 1970;50:229-31.
42. Tanenbaum L, Anderson C, Rosenberg MJ, Howard W, McDaniel W, Neimanis A, et al. Sulconazole nitrate 1% cream: a comparison with miconazole in the treatment of tinea pedis and tinea cruris corporis. Ther Clinician 1982;30:105-7, 115, 118.
43. Woscoff A, Carabeli S. Treatment of tinea pedis with sulconazole nitrate 1% cream or miconazole nitrate 2% cream. Curr Ther Res Clin Exp 1986;39:753-7.
44. Thomas DJ. A study in industry of clotrimazole cream in tinea pedis and tinea cruris. Curr Med Res 1976;3:630-3.
45. Tsuboi R, Matsumoto T, Ogawa H, Kuriya N, Yoshiike T, Nishiyama C, et al. Hyperkeratotic chronic tinea pedis treated with neticonazole cream. Int J Dermatol 1996;35:371-3.
46. Greer D, Jolly HW. Comparative trial of a two-dosage schedule of ketoconazole 2% cream for the treatment of tinea pedis. J Am Acad Dermatol 1987;17:53-6.
47. Roberts DT, Adriiaans B, Gentles JC. A comparative study of once daily bifonazole cream versus twice daily miconazole cream in the treatment of tinea pedis. Mykosen 1985;28:550-2.
48. Friederich HC, Hagedorn M, Lachnitt H. Effectiveness of mycospor cream in foot mycosis. Z Allgemein Med 1992;68:325-9.
49. Ablon G. Rosen T, Spedale J. Comparative efficacy of naftifine oxiconazole and terbinafine in short term treatment of tinea pedis. Int J Dermatol 1996;35:591-3.
50. Smith EB, Wiss K, Hanifin JM, Jordon RE, Rapini RP, Lasser AE, et al. Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis. J Am Acad Dermatol 1990;22:116-7.
51. Korting HC, Klovekorn W, Klovekorn G, Ecosom Collaborative Study Group. Comparative efficacy and tolerability of econazole liposomal gel 1%, branded econazole conventional cream 1% and generic clotrimazole cream 1% in tinea pedis. Clin Drug Invest 1997;14:286-93.
52. Zaug M, Bergstraesser M. Amorolfine in the treatment of onychomycosis and dermatomycosis: an overview. Clin Exp Dermatol 1992;17(suppl 1):61-70.
53. Bergstresser PR, Elewski B, Hanifin J, Lesher J, Savin R, Shupack J, et al. Topical terbinafine and clotrimazole in interdigital tinea pedis: a multi centre comparison of cure and relapse rates with one- and four-week treatment regimens. J Am Acad Dermatol 1993;28:648-51.
54. Evans EGV, Seaman RAJ, James IGV. Duration therapy with terbinafine 1% cream in dermatophyte skin infections. Br J Dermatol 1994;130:83-4.
55. Elewski B, Jones T, Zaias N. Comparison of an antifungal agent used alone with an antifungal used with a topical steroid in inflammatory tinea pedis. Cutis 1996;58:305-7.
56. Fuerst JF, Cox GF, Weaver SM, Duncan WC. Comparison between undecylinic acid and tolnaftate in the treatment of tinea pedis. Cutis 1980;25:544-9.
57. Tschen EH, Becker LE, Ulrich JA, Hoge WH, Smith EB. Comparison of over the counter agents for tinea pedis. Cutis 1979;23:696-8.
58. Tong MM, Altman PM, Barnetson RStC. Tea tree oil in the treatment of tinea pedis. Australas J Dermatol 1992;33:145-9.
59. Ellis CN, Gammon WR, Goldfarb MT, Griffin TB, Jegosothy BV, Kamm AR, et al. A placebo-controlled evaluation of once-daily versus twice-daily oxiconazole nitrate (1%) cream in the treatment of tinea pedis. Curr Ther Res 1989;46:269-76.
60. Smith E, Powell RF, Graham JL, Ulrich JA. Topical undecylinic acid in tinea pedis: a new look. Int J Dermatol 1977;16:52-6.
61. Albanese G, Di Cintio R, Giorgetti P, Galbiati G, Ciampini Ml. Recurrent tinea pedis: a double blind study on the prophylactic use of fenticonazole powder. Mycoses 1992;35:157-9.
62. Alexander JOD, Grant PW. The treatment of skin infections: a double-blind trial of fentiderm. Clin Trials J 1972 9:9-12.
63. Athow-Frost TAM, Freeman K, Mann TAN, Marks R, Vollum D, Warin AP. Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole cream. Curr Med Res 1986;10:107-16.
64. Avila JM. Treatment of dermatomycoses with sulconazole 1% nitrate cream or miconazole nitrate 2% cream: a double-blind comparative study. Curr Ther Res Clin Exp 1985;38:328-33.
65. Bjornberg A, Tegner E. Treatment of tinea with miconazole and miconazole-hydrocortisone. Curr Ther Res 1986;40:471-4.
66. Clayton YM, Hay RJ, McGibbon DH, Pye RJ. Double-blind comparison of the efficacy of tioconazole and miconazole for the treatment of fungal infection of the skin. Clin Exp Dermatol 1982;7:543-51.
67. Cuce LC, Contijo Assuncao BF, Medawar LGA, Salibian A, Groppi W. Tolciclate versus miconazole: a double-blind trial in patients with dermatomycosis. J Int Med Res 1980;8:144-7.
68. Cuce LC. Sulcanazole nitrate 1% cream versus clotrimazole 1% cream in the treatment of tinea pedis. Curr Ther Res Clin Exp 1989;45:421-7.
69. Del Palacio A, Gip L, Bergstraesser M, Zaug M. Dose-finding study of amorolfine cream (0.125%, 0.25% and 0.5%) in the treatment of dermatomycoses. Clin Exp Dermatol 1992;17(suppl 1):50-5.
70. Del Palacio A, Lopez-Gomez S, Cuetara S, Iglesias-Diez L, Rodriguez-Noriega A. Experience with amorolfine in the treatment of dermatomycoses. Dermatology 1992;184(suppl 1):25-9.
71. Del Palacio A, Lopez S, Gimeno C, Garcia-Lacalle C, Cuetara S, Garcia-Bravo M, et al. Randomized comparative study: amorolfine cream (0.125%, 0.25% and 0.5%) in dermatomycoses. J Dermatol Treatment 1991;1:299-303.
72. Effendy I, Friederich HC. Double-blind randomised comparative trial of naftifine solution (once daily) and clotrimazole solution (twice daily) in the treatment of dermatomycoses. Mykosen 1987;30:104-11.
73. Evans EGV. A comparison of terbinafine (Lamisil) 1% cream given for one week with clotrimazole (Canesten) 1% cream given for four weeks in the treatment of tinea pedis, Br J Dermatol 1994;130:2-4.
74. Fredriksson T. Topical treatment with BAY b 5097: a new broad-spectrum antimycotic agent. Br J Dermatol 1972;86:628-30.
75. Fredriksson T. Topical treatment of superficial mycoses with clotrimazole. Post Grad Med J 1974;50:62-4.
76. Fredriksson T. Treatment of dermatomycosis with topical miconazole (Daktar). Opusc Med 1977;22:80-1.
77. Fredriksson T. Treatment of dermatomycosis with topical tioconazole and miconazole. Dermatologica 1983;166:14-9.
78. Fulton JEJ. Miconazole therapy for endemic fungal disease. Arch Dermatol 1975;111:596-8.
79. Galimberti RL, Belli L, Negroni R, Castro JM, Rohwedder R, Tuculet MA. Prophylaxis of tinea pedis interdigitalis with bifonazole 1% powder. Dermatologica 1984;169(suppl 1):111-6.
80. Gip L, Forsstrom S. A double-blind parallel study of sulconazole nitrate 1% cream compared with miconazole nitrate 2% cream in dermatophytoses. Mykosen 1983;26:231-41.
81. Greer DL. Topical treatment for moccasin-type tinea pedis. J Am Acad Dermatol 1987;16:554-8.
82. Grigoriou D, Grigoriou A. A double-blind comparison of the efficacy, toleration and safety of tioconazole base 1% and econazole nitrate 1% creams in the treatment of patients with fungal infections of the skin or erythasma. Dermatologica 1983;166(suppl 1):8-13.
83. Grooten A, Meijman FJ. The treatment of the dermatomycoses of toes, feet and inguinal region: comparative study on the efficacy of miconazole and Whitfield’s ointment. Huisarts Wet 1992;35:26-8.
84. Kashin P, Ohyfferoen MC, Gibbs DL. A comparative study of once- versus twice-daily treatment of superficial dermatophyte and yeast infections with tioconazole 1% cream. J Int Med Res 1985;13:85-95.
85. Katayama H. The treatment of tinea with topically applied leukotriene B4. Prostaglandins 1987;34:797-804.
86. Kates SG, Myung KB, McGinley KJ, Leyden JJ. The antibacterial efficacy of econazole nitrate in interdigital toe web infections. J Am Acad Dermatol 1990;22:583-6.
87. Katz R. Haloprogen therapy for dermatophyte infections. Arch Dermatol 1972;106:837-8.
88. Lassus A, Forstrom S, Salo O. A double-blind comparison of sulconazole nitrate 1% cream with clotrimazole 1% cream in the treatment of dermatophytoses. Br J Dermatol 1983;108:195-8.
89. Lassus A, Nolting KS, Savopoulos C. Comparison of ciclopiroxolamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses. Clin Ther 1988;10:594-9.
90. Lestienne MC, Chemali R, Tennstedt D, Vanaele R, Lachapelle JM, Lapiere CM. Double-blind comparison of econazole spray powder and placebo as therapy and prophylaxis of athlete’s foot. Mykosen 1982;25:335-40.
91. Lison EM, Pearson BG, Goodfellow RC. Athlete’s foot: a step forward. Occup Health 1985;37:66-70.
92. Lynfield YL, Littman ML, Feingold LE. Treatment of tinea pedis with micronized griseofulvin and tolnaftate. Cutis 1974;13:460-2.
93. Maibach HI. Iodochlorhydroxyquin-hydrocortisone treatment of fungal infections. Arch Dermatol 1978;114:1773-5.
94. McVie DH, Littlewood S, Alle BR, Pollock AC, Wood P, Milne LJR. Sulconazole versus clotrimazole in the treatment of dermatophytosis. Clin Exp Dermatol 1986;11:613-8.
95. Meinicke K, Streigel C, Weidinger G. Treatment of dermatomycoses with naftifine: therapeutic efficacy on application once daily and twice daily. Mykosen 1987;30:98-103.
96. Mertens RLJ, Morias J, Verhanmme G. A double-blind study comparing Daktacort, miconazole and hydrocortisone in inflammatory skin infections. Dermatologica 1976;153:228-35.
97. Nolting S, Reinel D, Semig G, Reckers-Czaschka R, Bergstraesser M. Amorolfine spray in the treatment of foot mycoses (dose finding study). Br J Dermatol 1993;129:170-4.
98. Nolting S, Semig G, Fredrich HK, Dietz M, Reckers-Czaschka R, Bergstraesser M, et al. Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses. Clin Exp Dermatol 1992;17(suppl 1):56-60.
99. Oyeka CA, Gugnani HC. Isoconazole nitrate versus clotrimazole in foot and nail infections due to hendersonula toruloidea, scytalidium hyalinum and dermatophytes. Mycoses 1992;35:357-61.
100. Pariser DM, Pariser RJ. Oxiconazole nitrate lotion 1%C an effective treatment for tinea pedis. Cutis 1994;54:43-4.
101. Qadripur SA. Double-blind parallel comparison of sulconazole nitrate 1% cream and powder with econazole 1% cream and powder in the treatment of cutaneous dermophytoses. Curr Ther Res Clin Exp 1984;35:753-8.
102. Shellow WVR. 2% miconazole nitrate powder in aerosol spray form: its efficacy in treating tinea pedis. J Int Med Res 1982;10:28-31.
103. Smith E, David LM, Knox JM. Topical clotrimazole in dermatophytosis in a prison environment. Post Grad Med J 1974;50(suppl 1):64-6.
104. Stettendorf S. Tolerability and efficacy of bifonazole in dermatomycoses. Arzneimittel Forschung 1983;33:750-4.
105. Tanenbaum L, Anderson C, Rosenberg M, Dorr A. A new treatment for cutaneous candidiasisC sulconazole nitrate cream 1%. Int J Dermatol 1983;22:318-20.
106. Weil M, Elewski B. Topical econazole versus terbinafine in the treatment of toe web space infections: a comparison. Adv Ther 1996;13:355-64.
107. Buck DS, Nidorf DM, Addino JG. Comparison of two topical preparations for the treatment of onychomycosisC tea tree oil and clotrimazole. J Fam Pract 1994;38:601-5.
108. Mensing H, Polak-Wyss A, Splanemann V. Determination of the subungual antifungal activity of amorolfine after one month’s treatment in patients with onychomycosis: a comparison of two nail lacquer formulations. Clin Exp Dermatol 1992;17(suppl 1):29-32.
109. Lauharanta J. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly. Clin Exp Dermatol 1992;17(suppl 1):41-3.
110. Reinel D. Topical treatment of onychomycosis with amorolfine 5% nail lacquer: comparative efficacy and tolerability of once- and twice-weekly use. Dermatology 1992;184(suppl 1):21-4.
111. Reinel D, Clarke C. Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis: once weekly versus twice weekly. Clin Exp Dermatol 1992;17(suppl 1):44-9.
112. Ruping KH, Haas PJ. Treatment of onychomycosis: bifonazole nail set in comparison with urea. Zeitschr Artzliche Fortbild 1993;87:425-9.
113. Terragni L, Caputo R. Efficacy and tolerability of Kevis nails associated with an antimycotic product in the treatment of onychomycosis: a double-blind study versus placebo plus antimycotic product. G Ital Dermatol Venereol 1993;128:XLI-XLIII.
114. Arenas R, Fernandez G, Dominguez L. Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent. Int J Dermatol 1991;30:586-9.
115. Friedman-Birnbaum R, Cohen A, Shemer A, Bitterman O, Bergman R, Stettendorf S. Treatment of onychomycosis: a randomised double-blind study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin. Int J Dermatol 1997;36:67-9.
116. Zaug M. Amorolfine nail lacquer: clinical experience in onychomycosis. J Eur Acad Dermatol Venereol 1995;4:23-30S.
117. Altman DG. Practical statistics for medical research. London: Chapman and Hall, 1991.
118. Netten A, Dennet J. Unit costs of health and social care. University of Kent at Canterbury: Personal Social Services Research Unit, 1997.
119. Egger M, Davey-Smith G. Meta-analysis: bias in location and selection of studies. BMJ 1998;316:61-6.
120. Speikerman PH, Young MD. Clinical evaluation of clotrimazoleC a broad-spectrum antifungal agent. Arch Dermatol 1976;112:350-2.
121. Smith EB, Graham JL, Ulrich JA. Topical clotrimazole in tinea pedis. South Med J 1977;70:47-8.
122. Akers WA, Lane A, Lynfield Y, Greenberg J, Hall J, Mangan C, et al. Sulconazole nitrate 1% cream in the treatment of chronic moccasin-type tinea pedis caused by trichophyton rubrum. J Am Acad Dermatol 1989;21:686-9.
123. Aly R, Bayles CI, Oakes RA, Bibel DJ, Maibach HI. Topical griseofulvin in the treatment of dermatophytoses. Clin Exp Dermatol 1994;19:43-6.
124. Smith EB, Becker LE, Tschen EH, Way B, Way A. Topical tioconazole in tinea pedis. Adv Ther 1988;5:313-8.